x

Zoek een onderzoeksproject

* (*) verplicht veld

66 Resultaat/Resultaten

Sorteer op

Gefinancierd door een IRDiRC-lid =

Onderzoeksprojecten

DUITSLAND

Bayern
MARTINSRIED

Cellular Toxicity of Polyglutamine Proteins in Neurodegenerative Disease
Max-Planck-Institut für Biochemie
Abteilung zelluläre Biochemie

DUITSLAND

Hessen
FRANKFURT AM MAIN

CAG102-knock-in model for spinocerebellar ataxia type 2
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Klinik für Neurologie

DUITSLAND

Hessen
FRANKFURT AM MAIN

The effect of normal and pathological ataxin-2 on regulation of protein synthesis in neurons
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Klinik für Neurologie

FRANKRIJK

ILE-DE-FRANCE
PARIS

BIOSCA:Biomarkers in Autosomal Dominant Cerebellar Ataxia
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
UF de Neurogénétique Moléculaire et Cellulaire

VERENIGD KONINKRIJK

Greater London
LONDON

Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
National Hospital for Neurology and Neurosurgery
Sobell Department of Motor Neuroscience and Movement Disorders

VERENIGD KONINKRIJK

Greater London
LONDON

Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience

DUITSLAND

Schleswig-Holstein
LÜBECK

Phenotypic spectrum and molecular characterization of Movement disorders
Universität Lübeck
Institut für Neurogenetik

FRANKRIJK

ILE-DE-FRANCE
PARIS

Gefinancierd door een IRDiRC-lidSPATAX-QUEST: Identification of new causative genes in spinocerebellar degenerations by combination of whole genome scan, next-generation sequencing and biological validation in vitro and in vivo
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIË

LAZIO
ROMA

SPATAX: European network for hereditary spinocerebellar degenerative disorders
Fondazione EBRI
Istituto di Neurobiologia e Medicina Molecolare

ITALIË

PIEMONTE
TORINO

Identification of the gene responsible for a novel form of autosomal dominant spinocerebellar ataxia
A.O. Città della Salute e della Scienza di Torino - Ospedale Molinette
Genetica Medica

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Centro de Genética Preditiva e Preventiva

PORTUGAL

NORTE
PORTO

Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

Mapping and identification of new disease genes in autosomal dominant spinocerebellar ataxias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
SANTA MARIA DA FEIRA

VERENIGD KONINKRIJK

Berkshire
READING

VERENIGD KONINKRIJK

Greater London
LONDON

Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias
Barts and The London School of Medicine and Dentistry
Centre for Neuroscience and Trauma

VERENIGD KONINKRIJK

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience

VERENIGD KONINKRIJK

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
UCL Institute of Child Health, University College London
Metabolic Unit

VERENIGD KONINKRIJK

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
University College London Hospitals, NHS Foundation Trust
Department of Chemical Pathology

VERENIGD KONINKRIJK

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
PMARC - The University of Edinburgh
Perception-Movement-Action Research Consortium

VERENIGD KONINKRIJK

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
School of Informatics, The University of Edinburgh
Human Communication Research Centre

VERENIGD KONINKRIJK

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Churchill Hospital
Department of Clinical Genetics

VERENIGD KONINKRIJK

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Churchill Hospital
Oxford Medical Genetics Laboratories

VERENIGD KONINKRIJK

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Henry Wellcome Building for Molecular Physiology
BRC Genetics and Pathology Theme

VERENIGD KONINKRIJK

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Le Gros Clark Building - University of Oxford
MRC Functional Genetics Unit

DUITSLAND

Baden-Württemberg
TÜBINGEN

Gefinancierd door een IRDiRC-lidNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Institut für Medizinische Genetik und angewandte Genomik

DUITSLAND

Nordrhein-Westfalen
BONN

DUITSLAND

Nordrhein-Westfalen
KÖLN

Gefinancierd door een IRDiRC-lidNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Humangenetik am Universitätsklinikum Köln
Institut für Humangenetik

FRANKRIJK

ILE-DE-FRANCE
PARIS

Gefinancierd door een IRDiRC-lidNeuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases - FR
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIË

LOMBARDIA
MILANO

Gefinancierd door een IRDiRC-lidNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari
Laboratorio di Biologia delle Cellule Staminali

USA

Arizona
PHOENIX

Gefinancierd door een IRDiRC-lidThe etiology of inherited neurological diseases
Phoenix Children's Hospital
Barrow Neurological Institute

VERENIGD KONINKRIJK

Greater Manchester
ADDRESS: NOT PROVIDED - UK

FRANKRIJK

ILE-DE-FRANCE
PARIS

Gefinancierd door een IRDiRC-lidSTaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FRANKRIJK

PAYS DE LA LOIRE
NANTES

Gefinancierd door een IRDiRC-lidFROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

ITALIË

CAMPANIA
NAPOLI

Gefinancierd door een IRDiRC-lidTelethon Undiagnosed Disease Program - Revised Proposal
TIGEM - Telethon Institute of Genetics and Medicine
Genomic Medicine - Telethon Institute of Genetics and Medicine

VERENIGD KONINKRIJK

Lothian
EDINBURGH

Genetic disorders of human brain development
Western General Hospital
MRC Human Genetics Unit

VERENIGD KONINKRIJK

Oxfordshire
OXFORD

DUITSLAND

Bayern
MÜNCHEN

Gefinancierd door een IRDiRC-lidRHAPSODY - Research to Assess Policies and Strategies for Dementia in the Young
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für Psychiatrie und Psychotherapie

Multicentrische onderzoeksprojecten